codon sequence. The suppressor (Su) tRNA gene was introduced into monkey kidney cells (CV-1) by using simian virus 40 (SV40) DNA as vector (SV40-tRNAT"`Su'). CV-1 cells infectedwith virus containing the mutant, but not the wild-type, tRNA gene produce a functional amber suppressor tRNA as indicated by suppression of amber mutations in co-infecting adenovirus serotype 2-SV40 hybrids. Further evidence that suppression of these amber mutations is tRNA mediated was derived by isolation of total tRNA from CV-1 cells infected with the SV40-tRNATYr (Su') recombinant and its use in demonstration of read through of an amber codon during in vitro translation of tobacco mosaic virus RNA in reticulocyte extracts. Interestingly, the amplification of an amber suppressor gene in CV-1 cells does not interfere with SV40 production, suggesting that suppression of amber codons may not be very deleterious to mammalian cell metabolism.
Isolation ofEscherichia coli cells with a wide variety ofnonsense suppressor (Su) mutations was crucial for much ofthe early work on genetic analysis of chain-terminating mutations in bacterial and viral genomes (for review, see ref. 1) . Suppressors of all three nonsense codons, UAG (amber), UAA (ochre), and UGA have been characterized in E. coli. Among eukaryotic organisms, tRNA-mediated suppression has been studied extensively only in yeast. Quite recently, an amber suppressor has been identified in Caenorhabditis elegans and shown to involve changes in a tRNA (ref. 2 ; N. Willis, R. Gesteland, K. Bolten, and B. Waterston, personal communication).
The availability of mammalian cell lines with well-defined tRNA suppressors would greatly facilitate genetic analysis of nonsense mutants in mammalian cells and, in particular, animal viral genomes. As a step toward this objective, we report here the generation of an amber suppressor derived from Xenopus laevis tyrosine tRNA gene. We have introduced this amber suppressor tRNA gene into monkey kidney cells (CV-1) by using simian virus 40 (SV40) DNA as vector. We show that the tRNA gene is expressed and produces a functional tRNA that suppresses-amber mutations both in vivo and in vitro. In particular, the in vivo activity of the suppressor tRNA gene is shown by the fact that previous infection ofCV-1 cells with the SV40-tRNA suppressor recombinant efficiently suppresses the amber nonsense mutation in the 30,000-dalton fusion protein of two mutants of adenovirus serotype 2(Ad2)-SV40 hybrid (Ad2+NDl) isolated by Grodzicker et aL (3, 4) .
MATERIALS AND METHODS
Construction of M13-tT (Su') by Site-Specific Mutagenesis. The oligonucleotide primer C-A-C-C-T-A-G-A-G-T-C-C-T was synthesized by using a modified phosphotriester method (ref. 5 New England BioLabs; 1,100 units/ml) and 1.5 ,u1 ofT4 ligase (New England BioLabs, 4 x 105 units/ml) were added. After 2 hr at 370C, the reaction mixture was loaded onto an agarose gel containing ethidium bromide at 0.6 ug/ml. Covalently closed circles were purified from the agarose gel and used for transfection. The sequence of M13-tT (Su+) DNA was determined by using the Maxam and Gilbert procedure (7) .
Cloning of tRNAT), Genes (wt and Su') into SV40. M13-tT and M13-tT (Su') DNAs were cleaved with Kpn I [ in the SV40 sequences at map unit (m.u.) 0.72] and EcoRI (in the M13mp5 polylinker adjacent to the SV40 HindIll site at m.u. 0.86) and the DNA fragments containing the tRNA gene were purified by gel electrophoresis. These fragments were cloned by using a pBR322-SV40 recombinant (joined at the BamHI sites) that had been cleaved with Kpn I (at SV40 m.u. 0.72) and EcoRI (at SV40 m.u. 1.0). The tRNA gene was thus placed in the late region of SV40 in the same polarity as late mRNA transcription. The resulting clones were designated pSV-tT-2 and pSV-tT-2(Su+) (see Fig. 3A ).
Production of Recombinant SV40 Virus Stocks and Purification of DNA and RNA. E. coli plasmids and strains, SV40 virus stocks, mammalian cell lines, and plasmid DNA preparations for transfection ofCV-1 cells were as described (8) . Virus stocks were prepared by excision of the viral DNAs from pBR322 sequences by digestion with the appropriate restriction endonuclease, circularized by ligase, and used to transfect CV-1 cells by using DEAE-dextran (9 The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
conditions with 32P04 were as described (8) . 32P-Labeled DNA and RNA were purified by Hirt extraction (10) followed by one phenol extraction, two phenol/chloroform extractions, and two ethanol precipitations.
Immunoprecipitations. Immunoprecipitations were by the Staphylococcus aureus method (11) after previous extensive incubation with nonimmune serum. Cell line 412 (12) , which produces a monoclonal antibody against the COOH-terminus of SV40 large tumor antigen (T antigen), was a gift of E. G. Gurney, University of Utah.
RESULTS
Site-Specific Mutagenesis ofX. laevis tRNATYr Gene Cloned into M13mp5. The sequence of a X. laevis gene for tRNATYr (13) is shown in Fig. 1 . A 263-base-pair (bp) fragment containing this gene has previously been cloned into the'late region ofSV40 and its expression has been studied after infection of monkey cells (8) . The X. laevis gene is efficiently transcribed and the tRNA is processed and modified.
The basic scheme for site-specific mutagenesis (6, 15, 16) (1) Fig. 1 ), carrying the X. laevis tRNATYr gene, as a template for the synthesis of covalently closed circular duplex DNA in the presence of an oligonucleotide as primer. The 13-base-long oligonucleotide primer used contains a mismatch in the anticodon region of the tRNA gene ( Fig. 1 ). To ensure specific priming by the oligonucleotide, the M13-tT DNA used was freed of DNA fragments by alkaline sucrose gradient centrifugation. Conditions for specific priming were established by using 5'-32P-labeled oligonucleotide primer and analyzing the elongation product'by digestion with HindIII followed by gel electrophoresis. As expected, more than 50% of the radioactivitywas found in the small 873-bp HindIII fragment that contains the tRNATYr gene (data not shown).
The oligonucleotide primed product should contain both incomplete and complete duplex DNAs. Because incomplete duplex DNAs could contribute to high wt background, covalently closed duplex DNAs were purified by electrophoresis in an agarose gel in the presence of ethidium bromide at 0.6 ug/ml and then used to transfect E. coli. Forty independent phage plaques were screened for the desired site-specific mutation. Phage from each plaque were used to infect E. coli, replicative form DNAs were isolated from the infected cells and analyzed by digestion with HinfI followed by electrophoresis on a 5% polyacrylamide gel. The desired mutation generates a new HinfI site within the tRNA gene (Fig. 1) . Two clones containing the new HinfI site were further analyzed and both were confirmed to possess the desired mutation by DNA sequence analysis (7) . An autoradiograph of a sequencing gel covering the anticodon regions ofthe mutant [tRNATYr (Su+)] and wt tRNATYr genes is shown in Fig. 2 .
Cloning of the Mutant tRNA Gene in CV-1 Cells by Using SV40. DNA segments from the M13 recombinants containing the tRNA genes were excised and cloned into the late region of SV40 DNA (Fig. 3a) . Identical constructs were prepared with the wt X. laevis tRNA gene and the tRNA (Su') gene. Virus stocks of the 'SV40 recombinants were prepared by co-transfection of CV-1 cells with a SV40 rat preproinsulin recombinant, SV-rINS-7, that has a deletion/substitution in the early gene region of SV40 ( Fig. 3a; unpublished results). Approximately 1 wk after co-transfection, the CV-1 cells underwent a cytopathic degeneration. The resulting virus stocks were harvested and labeled SV-tT-2/SV-rINS-7 and SV-tT-2 (Su')/SV-rINS-7.
Amplification of the amber suppressor gene in CV-1 cells does not interfere with SV40 reproduction (Fig. 3b) . A 10-cm plate of CV-1 cells infected with 0.1 ml of either SV-tT-2/SVrINS-7 or SV-tT-2 (Su')/SV-rINS-7 virus yielded comparable amounts of viral DNA 48 hr after infection [extracted by the method of Hirt (10) ]. Digestion of the 32P-labeled DNA with HindIII showed that each stock contained the two expected complementing viral genomes with no detectable contaminating wt SV40 DNA or variant DNA [Fig. 3b, lane 1 (SV40) , lane 2 (SV-tT-2 (Su+)/SV-rINS-7), and lane 3 (SV-tT-2/SV-rINS-7)]. Note the absence of fragment A in lanes 2 and 3. In addition, the amount of labeled viral DNA extracted from recombinant infected cells was comparable to that found 48 hr after infection with SV40 at a multiplicity ofinfection (moi) of 10 ( Fig. 3b; lanes 2 and 3) .
Expression of the X. laevis tRNAT)R Gene in CV-1 Cells. Expression of the tRNATyr(Su) gene in monkey cells was examined by labeling SV-tT-2 (Su+)/SV-rINS-7-infected cells with 32P04 46-52 hr after infection and analyzing total RNA for overproduction of tRNAs. Cells infected with an equal volume of SV-tT-2/SV-rINS-7 were analyzed in parallel. In both cases, the 32P-labeled RNA was resolved by electrophoresis in a 7.5% acrylamide/8.3 M urea gel. Fig. 4a shows that (i) the wt tRNATYr gene was efficiently expressed, yielding a prominent band migrating as expected for a 76-nucleotide-long tRNA (8) , and (ii) the tRNAT~r(Su') gene was expressed at about 1/5 the level of the wt gene but also yielded a. prominent band migrating as expected for a 76-nucleotide-long tRNA. Radioactive tRNA from these two bands was purified and analyzed. The RNase T1 maps of the wt tRNATyr and the tRNATYr(Su+) are shown in Fig. 4 b and c. As anticipated, an oligonucleotide A-C-U-C-f-A-m1Gp is found in the RNase T1 digest oftRNATYr(Su') (which results from the conversion of guanosine to cytidine in the anticodon) and the two olihonucleotides present in the wt tRNATyr (A-C-U-Gp and O-A-m Gp) are missing. (4) . The other Ad2+ND1 mutant, 71, was similarly identified as an ochre mutant.
CV-1 cells were infected with either SV-tT-2/SV-rINS-7 or SV-tT-2 (Su+)/SV-rINS-7 or mock and incubated at 370C for 24 hr to permit synthesis of viral encoded products, including tRNAs. These cultures were then infected with either Ad2+ND1, Ad2+ND1-71, Ad2+ND1-140, or Ad2+ND1-162. Cells were labeled with [3S]methionine and the SV40 T antigen-related proteins were immunoprecipitated by addition ofa monoclonal antibody (12) that immunoprecipitates the 30,000-dalton fusion protein. Gel analysis of the immunoprecipitated proteins is shown in Fig. 5 . The 30,000-dalton fusion protein is immunoprecipitated from CV-1 cells infected with Ad2+ND1 (lane 1) but not from cells infected with the Ad2+ND1 mutants (lanes 2, 3, and 4) nor from CV-1 cells previously infected with the SV40-X. laevis tRNATYr recombinant (SV-tT-2/SV-rINS-7) and then infected with either Ad2+ND1 mutant (lanes 8, 10, and 12). However, the amber mutants Ad2+ND1-140 and -162 were suppressed in CV-1 cells previously infected with the SV40 tRNATyr(Su) recombinant [SV-tT-2 (Su+)/SV-rINS-7; lanes 9 and 11). That suppression is efficient is indicated by the fact that a Biochemistry: Laski et becquerels; New England Nuclear) in 1 ml (total vol) for 1 hr. A total cell extract was made by lysis of the cell monolayer in 1 ml of RIPA buffer (18) . Proteins were then immunoprecipitated with a monoclonal antibody directed against the COOH terminus of SV40 T antigen.
Lanes: 1, mock infected followed by Ad2+ND1; 2, mock infected followed by Ad2WND1-71; 3, mock infected followed by Ad2WND1-140; 4, mock infected followed by-Ad2WND1-162; 5, SV-tT-2 (Su+)/SV-rINS- 7 followed by mock infected; 6, SV-tT-2/SV-rINS-7 followed by mock infected; 7, SV-tT-2 (Su+)/SV-rINS-7 followed by Ad2+ND1-71; 8, SVtT-2/SV-rINS-7 followed by Ad2+ND1-71; 9, SV-tT-2 (Su+)/SV-rINS-7 followed by Ad2WND1-140; 10, SV-tT-2/SV-rINS-7 followed by Ad2+ND1-140; 11, SV-tT-2 (Sut)/SV-rINS-7 followed by Ad2+ND1-162; 12, SV-tT-2/SVrINS-7 followed by Ad2+ND1-162. the amount of 30,000-dalton protein synthesized was equivalent to that found after Ad2'ND1 infection. Suppression is specific for amber mutations because synthesis ofthe 30,000-dalton fusion protein was not observed after infection with the ochre mutant, Ad2+ND1-71, (lane 7). In Vitro Suppression 'of Amber Codons by Su' tRNA :in Reticulocyte Extract. To show that the in vivo. suppression of amber codons was tRNA mediated, tRNA-enriched fractions extracted from CV-1 cells 48 hr after infection with either SV40 or the SV40 tRNA recombinants were -tested for their potency in promoting read through' of the amber termination signal in tobacco mosaic virus (TMV) RNA. Pelham (20) has previously shown that translation of TMV RNA in reticulocyte' extracts primarily yields a 110,000-dalton polypeptide. Addition of a yeast amber suppressor tRNA fraction to the extract promotes read through of termination to yield a 160,000-dalton polypeptide. As shown in Fig. 6 (lanes 1 and 6) , stimulation of synthesis of the same 160,000-dalton polypeptide was observed when tRNA fractions from CV-1 cells infectedwith'the SV40-tRNATYr (Su+) recombinant were added to the translation extract. This effect was not observed with tRNA fractions from CV-1 cells infected with either SV40 or the SV40tRNATYr recombinant or with mock-infected cells (Fig. .6) .
'DISCUSSION This paper describes the use ofsite-specific mutagenesis to generate an amber suppressor from a X. laevis tyrosine tRNA gene FIG. 6 . Electrophoretic. analysis of protein made in vitro by using TMV RNA as template and in the presence of crude tRNA from recombinant SV40-infected cells. Conditions for in vitro translation were a modification of that used by Pelham (20) . Rabbit reticulocyte lysate was prepared and treated with micrococcal nuclease as described by Peiham and Jackson (21) . Crude tRNA was isolated 48 hr after infection from SV-tT-2/SV-rINS7-,'SV-tT-2 (Su')/SV-r1NS-7-, SV4W-, and mock-infected cells. Cell (22) have also reported the isolation ofan amber suppressor tRNA derived from the human lysine tRNA gene and shown it to be active in suppression when injected into Xenopus oocytes.
Infection of CV-1 cells with SV40 recombinants containing the Su' gene produces a state fully permissive for translation of amber codons. Co-infection of these cells with mutants of Ad2+ND1 containing amber mutations in a 30,000-dalton fusion protein yielded levels of this protein comparable with those observed after infection-with an equal moi of wt Ad2'ND1. Suppression is specific for amber mutations (an ochre mutant ofAd2+ND1 was not suppressed under identical conditions) and is dependent on the single nucleotide change introduced.
It has been suggested that wild type tRNATYr which contains G instead of the modified nucleoside Q (queuosine) in the first position of the anticodon (23) can read amber codons. If so, it is unlikely that this kind of read through is an efficient process in mammalian cells. We have shown previously that the overproduced tRNATYr in cells infected with'the SV40-wt tRNATYr contains G in place of Q (8) . The presence of high levels of this tRNATYr species does not suppress the Ad2'ND1 amber mutants (Fig. 5, lanes 10 and 12) .
Amber codons in mammalian cells may, however, be read at a low frequency by certain endogenous tRNAs. An amber codon is known to separate the gag and pol genes of Moloney 5%16 Biochemistry: Laski et. d leukemia virus and a 1% read through could account for the amount of the 180,000-dalton gag-pol polypeptide synthesized (24) . The nature of tRNAs responsible for such a low level of read through is yet unknown. A number of amber mutants of viral and cellular genes have been identified: the Ad2-SV40 fusion protein gene ofAd2+ND1 (4), the thymidine kinase gene of herpes simplex virus (25) , the A gene of SV40 (26) , the hypoxanthine/guanine phosphoribosyltransferase gene (M. Capecchi, personal communication), and the human ,/3globin gene (27) . A low-level read through ofthese amber codons would not have been detected during the characterization ofmost ofthese mutants.
As shown here (Fig. 3) , amber suppressors are probably not highly deleterious for the viability of cells in culture. This may not be surprising because most mammalian genes terminate in UAA or UGA. By using the same procedures, it should be possible to generate amber suppressors derived from other tRNAs as well as UAA and UGA suppressors. It will be interesting to test whether the UAA and UGA suppressors are more deleterious to cells. The availability of a variety of nonsense suppressors in mammalian cells should permit isolation of many new nonsense mutants in viruses. Nonsense mutants are typically tight mutations. The isolation of many tight viral mutants should, in turn, make complementation and recombination assays ofanimal viruses more definitive. Finally, it should be possible to treat various regions ofa viral DNA with mutagens and, by using cells carrying suppressor genes, identify all the essential genes encoded in a segment of the viral DNA.
The most immediate objective in these studies is the creation of mammalian cells permissive for translation of nonsense mutations. Two approaches are possible: (i) as described here, a transient state can be established by previous infection of cells with the SV40-Su+ recombinant and (ii) a permanent permissive state could be established by isolation of cell lines expressing sufficient levels of the tRNATYr(Su+) from integrated DNA sequences. Given that the lytic cycle of SV40 extends over 4 days and that many other more lytic viruses form plaques within 24 hr, the first approach by itself should permit isolation of amber mutants of many lytic viruses. Obviously, it would be preferable to establish permanent permissive cell lines by integration of the X. laevis tRNATYr (Su') gene into a chromosome.
